With the imminent retirement of Professor Ian Charles, who has successfully led the Quadram Institute for over nine years, we are now looking to appoint a new Chief Executive Officer and Director. The Director is responsible for leading the ambitious future strategy for the Quadram Institute and for Quadram Institute Bioscience (QIB), building on the institute’s strengths, and promoting the institute as a world-class scientific research and innovation establishment.

As Director, you will develop, articulate and promote a future vision for the institute. Your leadership and experience will enable you to build on existing stakeholder relationships and enhance the Quadram Institute’s international reputation as a centre of excellence in food, gut microbiology and health. You will be an outstanding leader, ambassador and advocate, and will bring a track record of securing and exploiting research funding opportunities. You will contribute meaningfully to relevant national and international debate, and will represent QIB at the highest levels with a range of stakeholders from academia, government, BBSRC, UKRI, and industry.

Quadram Institute Bioscience (QIB) is a life science institute at the forefront of science and innovation and at the interface between food, gut biology, and health. Its research is targeted towards worldwide challenges in food-related disease and human health, bringing together interdisciplinary teams and working with international partner organisations to address these major issues. QIB is strategically supported by the Biotechnology and Biological Sciences Research Council (BBSRC) of UK Research and Innovation (UKRI). Through partnership with the BBSRC, University of East Anglia (UEA) and the Norfolk and Norwich University Hospitals NHS Foundation Trust (NNUH), QIB’s aim is to provide leadership in research and innovation, using the excellent facilities of the Quadram Institute, to transcend traditional boundaries.

QIB’s vision is to understand how food and microbes interact to promote health and prevent disease. By bringing together clinicians and researchers working in bioscience and genomics, nutrition and into human health, Quadram generates a pipeline of research with the potential to create solutions with verified benefits for human health. Based on the Norwich Research Park, QIB contributes to one of Europe’s largest single-site concentrations of research in food, microbiology, genomics and health.

Closing date for applications is close of business on Monday 17 June 2024.